Arteris Inc. Reports 28% Increase in Q1 2025 Revenue, Net Loss of $8.1 Million and EPS of $0.20

Reuters
2025/05/14
Arteris Inc. Reports 28% Increase in Q1 2025 Revenue, Net Loss of $8.1 Million and EPS of $0.20

Arteris Inc. reported its financial results for the first quarter of 2025, highlighting a strong performance with a record high ACV plus royalties of $66.8 million. The company achieved a non-GAAP positive free cash flow of $2.7 million, or 16% of revenue. Arteris posted a net loss of $8.1 million, with a Non-GAAP net loss of $3.6 million or $0.09 per share. The company's first-quarter results showed an improved operating loss of $7.7 million, compared to $9.1 million in the first quarter of 2024. The Non-GAAP operating loss was $3.2 million, down from $5.3 million in the same period last year. For the second quarter of 2025, Arteris provided guidance indicating expected ACV plus royalties between $66.0 million and $70.0 million, and anticipated revenue in the range of $16.1 million to $16.5 million. The forecast for Non-GAAP operating loss is between $3.0 million and $4.0 million, with free cash flow expected to be between a negative $5.0 million and $0.0. In addition to its financial performance, Arteris announced the opening of a new engineering and customer support center in Krakow, Poland, to enhance the development of its interconnect and SoC integration software. The company also received three awards in the annual American Business Awards, recognizing its innovation and product achievements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arteris Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9450739-en) on May 13, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10